Leverage and Pricing in Life Sciences Lending

7min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

This chapter discusses the complexities of leverage in the life sciences lending sector, including the use of loan-to-value approach and tranching to manage risk. It also explores the pricing structure of recent deals, resulting in a fixed income return of around 14 to 15 percent.

Expert View Series: Reorg Senior Private Credit Reporter Lucía Camblor speaks to Oaktree’s managing director, Aman Kumar, about direct lending in the life science sector, public-to-private transaction opportunities and Oaktree’s own private credit strategy. If you are not a Reorg subscriber, request access here: https://go.reorg-research.com/Podcast-Trial